Rolf Grempler

2.7k total citations · 1 hit paper
35 papers, 1.4k citations indexed

About

Rolf Grempler is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Rolf Grempler has authored 35 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Surgery. Recurrent topics in Rolf Grempler's work include Diabetes Treatment and Management (10 papers), Pancreatic function and diabetes (10 papers) and Metabolism, Diabetes, and Cancer (8 papers). Rolf Grempler is often cited by papers focused on Diabetes Treatment and Management (10 papers), Pancreatic function and diabetes (10 papers) and Metabolism, Diabetes, and Cancer (8 papers). Rolf Grempler collaborates with scholars based in Germany, United States and Japan. Rolf Grempler's co-authors include Michael Mark, Thomas Klein, Peter Eickelmann, Reinhard Walther, Dieter Schmoll, Frank Himmelsbach, Leo Thomas, Achim Sauer, Matthias Eckhardt and Dale E. Sharp and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Rolf Grempler

34 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Empagliflozin, a novel selective sodium glucose cotransporter‐2 (SGLT‐2) inhibitor: characterisation and comparison with other SGLT‐2 inhibitors

2011 494 citations Rolf Grempler, Leo Thomas et al. Diabetes Obesity and Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rolf Grempler Germany	16	806	734	585	151	126	35	1.4k
Deborah Hagan United States	7	542 0.7×	633 0.9×	542 0.9×	81 0.5×	76 0.6×	7	981
Eric T. Alexander United States	18	626 0.8×	443 0.6×	692 1.2×	88 0.6×	178 1.4×	27	1.4k
Ernst U. Frevert United States	16	1.2k 1.5×	408 0.6×	521 0.9×	277 1.8×	154 1.2×	24	1.7k
Manjula Chaddha United States	17	639 0.8×	740 1.0×	1.0k 1.7×	128 0.8×	89 0.7×	28	1.9k
Kyoichiro Tsuchiya Japan	19	501 0.6×	528 0.7×	413 0.7×	180 1.2×	84 0.7×	40	1.3k
Steven S. Mundt United States	15	375 0.5×	432 0.6×	398 0.7×	173 1.1×	61 0.5×	23	1.4k
Yanling He United States	20	503 0.6×	1.0k 1.4×	582 1.0×	88 0.6×	401 3.2×	48	1.5k
William R. Bensch United States	16	638 0.8×	347 0.5×	580 1.0×	138 0.9×	298 2.4×	18	1.6k
Constanze Bergt United States	11	446 0.6×	290 0.4×	364 0.6×	348 2.3×	59 0.5×	13	1.3k
Peter Eickelmann Germany	13	662 0.8×	534 0.7×	408 0.7×	49 0.3×	70 0.6×	19	1.0k

Countries citing papers authored by Rolf Grempler

Since Specialization

Citations

This map shows the geographic impact of Rolf Grempler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Grempler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Grempler more than expected).

Fields of papers citing papers by Rolf Grempler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf Grempler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Grempler. The network helps show where Rolf Grempler may publish in the future.

Co-authorship network of co-authors of Rolf Grempler

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf Grempler. A scholar is included among the top collaborators of Rolf Grempler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf Grempler. Rolf Grempler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wind, Sven, et al.. (2025). Relative Bioavailability of Zongertinib, an Orally Administered HER2-Selective Tyrosine Kinase Inhibitor, under Fed and Fasted Conditions in Healthy Male Participants: Results from Two Randomized, Open-Label, Crossover Studies. Molecular Pharmaceutics. 22(11). 6531–6538. 1 indexed citations

Sarkaria, Jann N., Maciej M. Mrugała, Kurt A. Jaeckle, et al.. (2024). A phase (Ph) 0/Ia study of brigimadlin concentration in brain tissue and a non-randomized, open-label, dose escalation study of brigimadlin in combination with radiotherapy (RT) in patients (pts) with newly diagnosed glioblastoma (GBM).. Journal of Clinical Oncology. 42(16_suppl). 2017–2017.

Roessner, Philipp M., et al.. (2024). The effect of carbamazepine, a strong CYP3A inducer, on the pharmacokinetics of zongertinib in healthy male volunteers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 45(2). 94–103. 2 indexed citations

Huisman, Marc C., Gerben J.C. Zwezerijnen, Rolf Grempler, et al.. (2023). 89Zr-immuno-PET using the anti-LAG-3 tracer [89Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC. European Journal of Nuclear Medicine and Molecular Imaging. 50(7). 2068–2080. 31 indexed citations

Hundertmark, Moritz, Olorunsola F. Agbaje, Ruth L. Coleman, et al.. (2021). Design and Rationale of the EMPA-VISION Trial: Investigating the Metabolic Effects of Empagliflozin in Patients with Heart Failure. ESC Heart Failure. 8(4). 2580–2590. 24 indexed citations

Grempler, Rolf, Michael W. Wolff, Eric J. Simon, et al.. (2018). Discovery and translation of a target engagement marker for AMP-activated protein kinase (AMPK). PLoS ONE. 13(5). e0197849–e0197849. 14 indexed citations

Luippold, Gerd, et al.. (2016). Short- and Longterm Glycemic Control of Streptozotocin-Induced Diabetic Rats Using Different Insulin Preparations. PLoS ONE. 11(6). e0156346–e0156346. 33 indexed citations

Vickers, Steven P., Sharon C. Cheetham, Keith Dickinson, et al.. (2014). Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet. Diabetes Metabolic Syndrome and Obesity. 7. 265–265. 55 indexed citations

Luippold, Gerd, Thomas Klein, Michael Mark, & Rolf Grempler. (2012). Empagliflozin, a novel potent and selective SGLT‐2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin‐induced diabetic rats, a model of type 1 diabetes mellitus. Diabetes Obesity and Metabolism. 14(7). 601–607. 65 indexed citations

10.

Vickers, Steven P., Sharon C. Cheetham, Helen L. Rowley, et al.. (2012). Effects of the DPP-4 Inhibitor, Linagliptin, in Diet-Induced Obese Rats: A Comparison in Naive and Exenatide-Treated Animals. Clinical Laboratory. 59(01+02/2013). 787–99. 11 indexed citations

11.

Thomas, Leo, Rolf Grempler, Matthias Eckhardt, et al.. (2011). Long‐term treatment with empagliflozin, a novel, potent and selective SGLT‐2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats. Diabetes Obesity and Metabolism. 14(1). 94–96. 42 indexed citations

12.

Grempler, Rolf, Leo Thomas, Matthias Eckhardt, et al.. (2011). Empagliflozin, a novel selective sodium glucose cotransporter‐2 (SGLT‐2) inhibitor: characterisation and comparison with other SGLT‐2 inhibitors. Diabetes Obesity and Metabolism. 14(1). 83–90. 494 indexed citations breakdown →

13.

Grempler, Rolf, Robert Augustin, Tobias Hildebrandt, et al.. (2011). Functional characterisation of human SGLT‐5 as a novel kidney‐specific sodium‐dependent sugar transporter. FEBS Letters. 586(3). 248–253. 60 indexed citations

14.

Grempler, Rolf, et al.. (2006). Tumor Necrosis Factor Alpha Induces the Expression of the Nuclear Protein p8 via a Novel NFκB Binding Site within the Promoter. Hormone and Metabolic Research. 38(9). 570–574. 13 indexed citations

15.

Grempler, Rolf, Susanne Günther, Knut R. Steffensen, et al.. (2005). Evidence for an indirect transcriptional regulation of glucose-6-phosphatase gene expression by liver X receptors. Biochemical and Biophysical Research Communications. 338(2). 981–986. 15 indexed citations

16.

Krüger, Klaus-Dieter, Dieter Schmoll, Rolf Grempler, et al.. (2004). Cellular models for the analysis of signaling by protein kinase B and the forkhead transcription factor FKHR (Foxo1a). Regulatory Peptides. 121(1-3). 19–24. 3 indexed citations

17.

Schmoll, Dieter, et al.. (2003). Expression of Thyroid Hormone Receptor Isoform α1 in Pancreatic Islets. Experimental and Clinical Endocrinology & Diabetes. 111(4). 198–202. 26 indexed citations

18.

Wasner, Christina, Rolf Grempler, Reinhard Walther, & Dieter Schmoll. (2001). Basal level glucose-6-phosphatase gene transcription requires binding sites for Sp family proteins within the gene promoter. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1521(1-3). 126–129. 7 indexed citations

19.

Schmoll, Dieter, Rolf Grempler, Andreas Barthel, Hans‐Georg Joost, & Reinhard Walther. (2001). Phorbol ester-induced activation of mitogen-activated protein kinase/extracellular-signal-regulated kinase kinase and extracellular-signal-regulated protein kinase decreases glucose-6-phosphatase gene expression. Biochemical Journal. 357(3). 867–867. 16 indexed citations

20.

Schmoll, Dieter, Kay S. Walker, Dario R. Alessi, et al.. (2000). Regulation of Glucose-6-phosphatase Gene Expression by Protein Kinase Bα and the Forkhead Transcription Factor FKHR. Journal of Biological Chemistry. 275(46). 36324–36333. 291 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact